Patents by Inventor Renee Yura

Renee Yura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treponema pallidum triplet antigen
    Patent number: 10125177
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: November 13, 2018
    Assignee: ORTHO-CLINICAL DIAGNOSTICS, INC.
    Inventors: Jian Zheng, Renee Yura, Jianping Yang
  • TREPONEMA PALLIDUM TRIPLET ANTIGEN
    Publication number: 20180141980
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Application
    Filed: January 9, 2018
    Publication date: May 24, 2018
    Applicant: Ortho-Clinical Diagnostics, Inc.
    Inventors: Jian ZHENG, Renee YURA, Jianping YANG
  • Treponema pallidum triplet antigen
    Patent number: 9902755
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: February 27, 2018
    Assignee: Ortho-Clinical Diagnostics, Inc.
    Inventors: Jian Zheng, Renee Yura, Jianping Yang
  • Treponema Pallidum Triplet Antigen
    Publication number: 20160115206
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 28, 2016
    Applicant: Ortho-Clinical Diagnostics, Inc.
    Inventors: Jian Zheng, Renee Yura, Jianping Yang
  • Treponema pallidum triplet antigen
    Patent number: 9221884
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Grant
    Filed: February 28, 2014
    Date of Patent: December 29, 2015
    Assignee: Ortho-Clinical Diagnostics, Inc.
    Inventors: Jian Zheng, Renee Yura, Jianping Yang
  • Treponema Pallidum Triplet Antigen
    Publication number: 20140178907
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Application
    Filed: February 28, 2014
    Publication date: June 26, 2014
    Applicant: Ortho-Clinical Diagnostics, Inc.
    Inventors: Jian Zheng, Renee Yura, Jianping Yang
  • triplet antigen
    Patent number: 8691950
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: April 8, 2014
    Assignee: Orth-Clinical Diagnostics, Inc.
    Inventors: Jian Zheng, Renee Yura, Jianping Yang
  • TREPONEMA PALLIDUM TRIPLET ANTIGEN
    Publication number: 20120237956
    Abstract: A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.
    Type: Application
    Filed: January 13, 2012
    Publication date: September 20, 2012
    Inventors: Jian Zheng, Renee Yura, Jianping Yang